Epigenetic reader domain inhibitor Bromodomain IN-1, Purity ≥98%

Cat. No.: X24-05-ZQ430

Epigenetic reader domain inhibitor Bromodomain IN-1, Purity ≥98%

Synonym: 1914120-48-1; Bromodomain IN-1; SCHEMBL19627342; US10124009, Compound 4; BDBM298349; AKOS040732667; Epigenetic reader domain inhibitor

  • CAS Number: 1914120-48-1
  • Compound CID: 132154361
Product Size
1 mg; 5 mg; 10 mg
Price
Datasheet
MSDS
Properties
Description
Bromodomain IN-1 disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals.
Molecular Weight
458.96
Molecular Formula
C22H23ClN4O3S
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Bromodomain IN-1 can be used to explore the impact of bromodomain inhibition on gene expression and disease states.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.